Machine learning (ML) applications in medical artificial intelligence (AI) systems have shifted from traditional and statistical methods to increasing application of deep learning models. This survey navigates the current landscape of multimodal ML, focusing on its profound impact on medical image analysis and clinical decision support systems. Emphasizing challenges and innovations in addressing multimodal representation, fusion, translation, alignment, and co-learning, the paper explores the transformative potential of multimodal models for clinical predictions. It also questions practical implementation of such models, bringing attention to the dynamics between decision support systems and healthcare providers. Despite advancements, challenges such as data biases and the scarcity of "big data" in many biomedical domains persist. We conclude with a discussion on effective innovation and collaborative efforts to further the miss
Machine learning (ML) applications in medical artificial intelligence (AI) systems have shifted from traditional and statistical methods to increasing application of deep learning models and even more recently generative models. Recent years have seen a rise in the discovery of widely-available deep learning architectures that support multimodal data integration, particularly with images. The incorporation of multiple modalities into these models is a thriving research topic, presenting its own unique challenges. In this work, we discuss five challenges to multimodal AI as it pertains to ML (representation, fusion, alignment, translation, and co-learning) and survey recent approaches to addressing these challenges in the context of medical image-based clinical decision support models. We conclude with a discussion of the future of the field, suggesting directions that should be elucidated further for successful clinical models and their translation to the clinical setting.
Early diagnosis of Type 2 Diabetes Mellitus (T2DM) is crucial to enable timely therapeutic interventions and lifestyle modifications. As medical imaging data become more widely available for many patient populations, we sought to investigate whether image-derived phenotypic data could be leveraged in tabular learning classifier models to predict T2DM incidence without the use of invasive blood lab measurements. We show that both neural network and decision tree models that use image-derived phenotypes can predict patient T2DM status with recall scores as high as 87.6%. We also propose the novel use of these same architectures as 'SynthA1c encoders' that are able to output interpretable values mimicking blood hemoglobin A1C empirical lab measurements. Finally, we demonstrate that T2DM risk prediction model sensitivity to small perturbations in input vector components can be used to predict performance on covariates sampled from previously unseen patient populations.